Dewey Kang is an associate in the New York office of Latham & Watkins and a member of the Data & Technology Transactions Practice.
Mr. Kang advises public and private companies, private equity funds, and financial institutions on complex commercial transactions where intellectual property and technology play key roles.
He represents clients across various sectors, including software, e-commerce, entertainment, e-sports, financial services, energy, retail, blockchain, and commercial products, in connection with M&A, cross-border and financing transactions, complex carve-outs, intellectual property strategy and commercialization, IP licensing, development agreements, and other commercial arrangements.
Prior to joining Latham, he was an IP associate at another international law firm, where his IP transactions and litigation experience spanned a diverse array of technologies and industries, including Wi-Fi, 5G, LTE 4G, wireless transmissions by smart meters and entertainment devices, user interface navigation in iOS and Android devoices, lithium-ion technology, renewable energy technology, semiconductor supply chain, financial services, telecom, networking, data encryption, biotechnology, and blockchain. Mr. Kang spent time on secondment to BNY Mellon, where he served as legal counsel in the Technology and Intellectual Property group.
Mr. Kang’s background in organic chemistry, medical research, and technology enables him to approach complex technical issues at multidisciplinary analytical angles, and further allows him to assist clients that have a wide range of IP portfolios in sectors ranging from general technology to biotechnology.
Prior to and throughout law school, Mr. Kang participated in an extensive number of mobile and desktop software QA projects; as well as mobile app and web development with special focus on UI/UX development; and consulted with startups across a broad range of topics, including developing strategies for growth both in technical R&D and investments. He also worked through college as student leader of the Information Technology Department, overseeing all IT matters across campus. Furthermore, Mr. Kang was a medical researcher at the Department of Neurosurgery at Yale School of Medicine, where his research in neurobiological and neurochemical studies involving the human epileptogenic tissue, and neuropathological effects of explosive blast-induced brain injuries, were published in prominent medical journals.